FDA Device

Titan Gel Serum Protein Control: SPE Control Cat. No 5136 1 x 2.0 mL

Hazard

Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range.

What You Should Do

Remedy

Between 10/14/2016 to 10/21/2016 a notification was emailed to the affected users informing them that Assay protocol had changed due to a Marketing decision to delete use of EDC, since it was a discontinued device (for over 10 years), creating a tighter assay range, but met QC specification. Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range, Technical Services began an MRA investigation. Investigation verified user complaint, and Lot was quarantined, and Rework action plans using EDC also were initiated for the device. This issue was found at a Users site, via use as system Quality Control material. The investigation focused on potential effects/risks, and cause. This issue was found at a Users site, via use as system Quality Control material. Customers reported a narrow assay range when compared to prior lots forcing some users out of the provided assay range. PUBLIC CONTACT: Title: Technical Services Manager Address: 1530 Lindbergh Drive, Beaumont, TX 77707 Telephone #: (409) 842-3714 x1177 Email: jhanka@helena.com

Products

Titan Gel Serum Protein Control: SPE Control Cat. No 5136 1 x 2.0 mL
Brand
Helena Laboratories, Inc.
UPC
Lot Codes: 1-16-5136 (Scheme: 1(st lot)-(of 20)16-(for C/N )5136)  LOT 1-16-5136 EXP 3-17  Model/Catalog Number: 5136  UDI: Primary DI - M52551360

Units Affected

65 kits